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Abstract
Background: There is limited evidence from multicenter, randomized controlled studies to inform planning and
implementation of antibiotic stewardship interventions in hospitals.
Methods: A cluster randomized, controlled, intervention study was performed in selected specialities (infectious
diseases, pulmonary medicine and gastroenterology) at three emergency care hospitals in Western Norway.
Interventions applied were audit with feedback and academic detailing. Implementation strategies included
co-design of interventions with stakeholders in local intervention teams and prescribers setting local targets
for change in antibiotic prescribing behaviour. Primary outcome measures were adherence to national guidelines,
use of broad-spectrum antibiotics and change in locally defined targets of change in prescribing behaviour. Secondary
outcome measures were length of stay, 30-day readmission, in-hospital- and 30-day mortality.
Results: One thousand eight hundred two patients receiving antibiotic treatment were included. Adherence to guidelines
had an absolute increase from 60 to 66% for all intervention wards (p = 0.04). Effects differed across specialties and
pulmonary intervention wards achieved a 14% absolute increase in adherence (p = 0.003), while no change
was observed for other specialties. A pulmonary ward targeting increased use of penicillin G 2 mill IU × 4 for
pneumonia and COPD exacerbations had an intended increase of 30% for this prescribing behaviour (p < 0.001).
Conclusions: Pulmonary wards had a higher increase in adherence, independent of applied intervention. The effect of
antibiotic stewardship interventions is dependent on how and in which context they are implemented. Additional
effects of interventions are seen when stakeholders discuss ward prescribing behaviour and agree on specific
targets for changes in prescribing practice.
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Background
Globally, the overuse and misuse of antibiotics, espe-
cially broad-spectrum agents, has accelerated the devel-
opment and selection of resistant bacteria [1–3]. The
increase in broad-spectrum antibiotic prescribing cannot
be explained by increased antibiotic resistance alone [4].
Antibiotic stewardship programs have been introduced
to hospitals worldwide to promote more prudent anti-
biotic use [5, 6]. The basis of stewardship programs are
evidence based clinical guidelines for antibiotic prescrib-
ing to ensure effective treatment for individual patients,
while minimizing development of antimicrobial resistance
(AMR). Adherence to antibiotic guidelines varies among
countries and institutions [6]. Interventions like audit with
feedback, providing a summary of clinical performance
over time and educational outreach through academic
detailing have been shown to be effective in increasing
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adherence. However, the need for studies addressing
cultural, contextual and behavioural determinants when
developing, implementing and reporting stewardship in-
terventions has been highlighted [6–9]. There is also a
need for more studies that apply behaviour change theory
to investigate effect on antibiotic use across hospitals, spe-
cialties and diagnoses to help identify the most effective
means of implementing interventions that are transferable
and generalizable [6, 10, 11]. We report here the findings
of a multicentre, cluster randomized controlled interven-
tion study, investigating the effect of behaviour change in-
terventions with stakeholder involvement and local target
setting for change in antibiotic prescribing [12].
Methods
Definitions
Substances of ATC-group J01 (Antibacterials for sys-
temic use), metronidazole tablets (P01AB01) and vanco-
mycin tablets (A07AA09) were included in the definition
of antibiotics for this study [13]. Broad-spectrum antibi-
otics were defined as penicillins with enzyme inhibitor
(J01CR), 2. and 3. generation cephalosporins (J01D C-D),
carbapenems (J01DH) and quinolones (J01MA), the five
groups targeted in the National Action Plan Against
Antibiotic Resistance in Health Services [14, 15].
Study design
This prospective, cluster randomized, controlled inter-
vention study was performed within three specialties at
three emergency care and teaching hospitals as a parallel
group study with three arms (Table 1).
Participants and data collection
Eligible clusters were wards within one of the medical
specialties; infectious diseases, pulmonary medicine and
gastroenterology at hospital A, B and C in Western
Norway. Specialties were selected based on infectious
diseases and pulmonary medicine having the highest
consumption of antibiotics in the included hospitals.
Gastroenterology was included since hospital B had a
joint medication storage area for the ward of pulmonary
medicine and the ward of gastroenterology. Hospital A
and B were tertiary care hospitals with 1100 and 600 beds,
respectively. Hospital C was a secondary care hospital
with 160 beds. For description of case mix, see Table 2.
Patients who received antibiotics during hospitalization
and were discharged from the study wards in the time
period from 10th of February to 11th of July 2014 were eli-
gible for inclusion in the study. Patients who received anti-
bioticprophylaxis, had orthopaedic prosthesis infections, or
had a hospital stay < 24 h or > 21 days were excluded.
Patients whose indication for treatment was not in the anti-
biotic guideline or whose antibiotics were discontinued at
day 1, was excluded. Only the first stay of readmitted
patients was included. Patients were included consecutively.
Patient data were collected manually from electronic med-
ical records. Data collected included patient demographics,
indication for antibiotic treatment, antibiotic prescribing,
microbiological test results, estimated glomerular filtration
rate (eGFR) on admission, length of stay, 30-day readmis-
sion, in-hospital and 30-day mortality and admittance
from- or discharge to other hospitals or nursing homes. In-
dications for antibiotic treatment were registered as docu-
mented in the medical record and not assessed for validity.
Broad-spectrum antibiotic use for study wards in the
period 2013–2015 was collected from the hospital pharma-
cies sales statistics and adjusted per 100 patient bed days.
Interventions
The primary intervention aim was to increase adherence
to The National Guidelines for Antibiotic Use in Hospitals
(hereafter guidelines), across diagnoses [16]. Each hospital
assigned local intervention teams of 1–2 physicians and 1
pharmacist to co-design and implement the interventions.
Authors I.S and J.S.W developed initial intervention con-
cepts, which were discussed in a regional meeting with all
project participants. Each intervention team then refined
the interventions to fit their local context. A common
presentation template was prepared for all intervention
sessions with information about antibiotic resistance, the
national antibiotic guideline, local antibiotic sales statistics
and principals of antibiotic dosing. All intervention teams
modified this material to fit the individual wards. Aca-
demic detailing sessions focused on recently admitted in-
fectious diseases patients, including cases with treatment
both adherent and non-adherent to guidelines. The teams’
selection of patient cases decided the focus in wards re-
ceiving academic detailing.
Audit with feedback wards had predefined target areas of
pneumonia and COPD exacerbations, as these patients
were frequently admitted to both intervention wards. Fifty
patients with these diagnosis were included consecutively
from February to April 2014 to get a reasonable overview
of prescribing practice over the given time period, without
excessive workload for the intervention teams. For the audit
data, intervention teams assessed adherence. The level of
detail and focus in the feedback was at the discretion of the
teams and varied between the two feedback wards.
Intervention ward physicians were invited to academic
detailing- or audit with feedback- group sessions in May
2014, led by local intervention teams. No specific threshold
for acceptable attendance was defined, but more than one
meeting was held if the intervention team considered the
attendance at the first meeting to be too low. Physicians
present at the main session at each ward were invited to
identify one or two specific challenges to be addressed as
local targets for improvement of antibiotic prescribing
based on discussions during the session. Specific actions to
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achieve targets were not included in the target discussions.
For details of interventions, see Table 1.
Outcomes
Primary outcome measures
1) Adherence to guidelines was assessed on the second
day of treatment to allow sufficient time for patients
to be reviewed by study ward physicians and
measured as percentage of correctly prescribed
empiric treatment (choice of active substance)
before and after interventions [16]. CRB-65 was
not routinely documented, so pneumonia and
severe pneumonia was assessed together (both
empiric treatments assessed as adherent). All
hospitals were committed to use the national
guideline, as recommendations were appropriate
with regards to local antibiotic resistance patterns.
2) Use of broad-spectrum antibiotics was assessed as
DDD/100 bed days in time series before and after
intervention. Broad-spectrum antibiotic use was
selected as an outcome measure because the guidelines
mainly recommend narrow-spectrum antibiotics as
empiric treatment and a shift towards guideline
adherent prescribing was expected to cause a
reduction in broad-spectrum antibiotic use.
3) Change in locally targeted prescribing behaviour
was assessed according to the defined targets and
compared before and after interventions.
Secondary outcome measures were length of stay,
30-day readmission and mortality (all cause in-house
and 30-day mortality). Patient outcomes were measured
to ensure that the interventions did not have any nega-
tive consequences for patient treatment.
Sample size
As baseline adherence to guidelines was unknown in
Norway, calculation of the sample size prior to the study
was challenging. According to the original research
protocol, we assumed an absolute 20% improvement in
adherence from 50% pre-intervention to 70% post-inter-
vention for each cluster. Given a power of 80% and a
type 1 error of 5%, the smallest number of subjects
needed to detect this difference was 93 both before and
after the intervention. Although this was sufficient for
the current study, we calculated at least 155 patients be-
fore and after intervention to answer additional research
questions listed in the original protocol. However, the
sample size calculations did not include intra-cluster
correlation coefficient (ICC) or comparison with a con-
trol group. Based on pre-intervention data of adherence
to guideline, ICC coefficient for this outcome was 0.012
with 95% CI (0.003, 0.053).
Randomization
Authors I.S and J.S.W. performed randomization and
assigned clusters to interventions by drawing lots of hos-
pital and intervention groups per specialty. Across the
hospitals, infectious diseases and pulmonary medicine re-
ceived both academic detailing and audit with feedback
and had a control group. Only two of the hospitals had
specific gastroenterology wards, so this specialty received
only one intervention and had a control group (Table 1).
Blinding
Prescribing physicians at the wards were not informed
about the study being performed during the baseline
period and were at that point blinded to intervention
group, with the exception of the physicians assigned to
the project teams. Control ward physicians were blinded
throughout the study period.
Assessment of adherence to guidelines was performed
blinded to the intervention- or treatment group, by using
syntax in SPSS. An adherence variable was generated,
combining the variable indication for treatment with the
variable for prescribed treatment. First choice of empiric
therapy was coded as adherent. Manual adjustment of ad-
herence of antibiotic prescriptions was made in patients
with antibiotic allergies or kidney failure.
Statistical analysis
Analyses were performed both per intervention group and
per specialty, but due to fewer patients than expected in the
post-intervention period, analysis per cluster was not per-
formed. Differences in study group characteristics pre- and
post-interventions were tested using Pearson’s chi-square
test for categorical data and independent two-sample t-test
for continuous data. Pearsons chi-square test was also
applied to test adherence to guidelines pre- and
post-interventions for individual intervention groups and
specialties. To test whether percentage of adherence to
guidelines or patient outcomes in intervention and specialty
groups changed differently over time compared with the
control group, we evaluated the group-by-period inter-
action term in simple logistic or linear regression models,
as appropriate. Adherence to guideline or patient outcome
were dependent variables, with group of intervention (audit
vs control/academic detailing vs control) or specialty (e.g.
pulmonary medicine vs control/infectious diseases vs con-
trol) and period (before-after) were independent variables
together with the interaction term. The level – and trend
effect of broad-spectrum antibiotic use (sales statistics) pre-
and post-intervention was estimated with the Interrupted
Times Series (ITS) analysis method described by the
Cochrane Effective Practice and Organisation of Care
(EPOC) group [17]. All tests were two-sided and p-values
< 0.05 was considered statistical significant for all analyses.
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Statistical analysis was conducted using SPSS for Windows,
version 24 and Stata SE for Windows, version 15.
Results
Patients
Two thousand four hundred five admissions were eligible
for inclusion. After applying exclusion criteria, 1802 unique
patients were included in analysis, 1279 and 523 patients in
the pre- and post-intervention periods respectively
(Table 2). The study period was fixed due to time-limited
allocation of project resources and mandatory information
of included patients. Interventions were conducted later
than originally planned due to practical considerations at
the study wards. This caused skewness in data with two
thirds of the patients included pre-interventions (Table 2).
Patient characteristics were similar pre- and post-interven-
tions, except for some differences in distribution of diagno-
ses in the audit with feedback group (Table 2).
Primary outcomes
Adherence to guidelines
Across all intervention wards, adherence to guideline in-
creased from 60% to 66% (p= 0.04), but when compared
with the control group, this was not significant (Table 3).
The effect of interventions differed largely between the
specialties. Infectious diseases and gastroenterology wards
displayed no effect of interventions on adherence, while
pulmonary medicine wards displayed significant effect of
interventions compared to the control group (Table 3).
Academic detailing and audit with feedback increased total
adherence to guideline by 14% and 13% respectively (abso-
lute increase), in the pulmonary wards (not shown in tables).
The audit with feedback intervention specifically tar-
geted pneumonia and COPD exacerbations. For these
diagnoses, the pulmonary medicine ward increased
adherence by 12% and infectious diseases ward by 2%
(not shown in tables).
Use of broad-spectrum antibiotics
Interrupted time series analysis showed that the overall trend
of activity-adjusted broad-spectrum antibiotic use pre- and
post-interventions was significantly improved, as was the
level at 12 and 18 months post intervention for the audit
with feedback group (Appendix: Table 5 and Fig. 1). The
gastroenterology intervention ward had a significant decrease
in the use of broad-spectrum antibiotics at 3 and 6 months,
but it increased thereafter (Appendix: Table 5 and Fig. 1). No
significant change in broad-spectrum antibiotic use was seen
at the intervention wards receiving academic detailing, the
control group and for other intervention wards per specialty
(Appendix: Table 5 and Fig. 1).
Local targets
Intervention wards were invited to set local targets for fol-
low up after the intervention sessions (Table 4). The pul-
monary ward at Hospital A had a significant and intended
30% increase in the targeted use of Penicillin G 2 mill IU ×
4 for patients with pneumonia and COPD exacerbations
post intervention (p < 0.001). The use of Ciprofloxacin at
the ward of gastroenterology was reduced at all time points
following the intervention, though not statistically signifi-
cant (Appendix: Table 6). The other study wards either a)
did not reach consensus on targets b) did not identify any
targets or c) the identified target was not evaluable.
Secondary outcome measures
When analysed per intervention, there was a decrease of
0.7 days in the mean length of stay for patients in the
audit with feedback group (p = 0.037) (Table 2). In the
academic detailing group, 30-days readmission had an
absolute decrease of 7.4% (p = 0.044). Compared with
Table 3 Percentage of adherence to antibiotic guidelines in periods before and after interventions were implemented








InteractionbBefore n (%) After n (%)
Intervention
Control All specialties 350/169 174 (50) 84 (50) 0 0.998
Interventions All specialties 929/354 556 (60) 234 (66) 6 0.04 0.252
Academic detailing All specialties 451/172 265 (59) 111 (65) 6 0.188 0.353
Audit with feedback Infectious diseases +
Pulmonary medicine
478/182 291 (61) 123 (68) 7 0.111 0.265
Specialty
Pulmonary medicine Both interventions 427/162 249 (58) 116 (72) 14 0.003 0.034
Infectious diseases Both interventions 424/153 268 (63) 99 (65) 2 0.741 0.857
Gastroenterology Academic detailing 78/39 39 (50) 19 (49) -1 0.896 0.556
aBy chi-square test per group
bBy logistic regression of given group vs control wards (all specialties), giving the p-value for the interaction between group and period
P-values < 0.05 are given in boldface
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the control group, these findings were not statistically
significant. In-hospital death, 30-day mortality, 30-day
readmission and length of stay for the other groups were
not significantly changed (Table 2).
Discussion
This study highlights the effect of engaging local stake-
holders (physicians) in setting specific targets for change in
antibiotic prescribing behaviours. A specific target area,
which is easy to remember and act upon, makes it possible
to achieve change within a short timeframe, as observed in
the pulmonary ward at Hospital A where adherence to tar-
geted behaviour increased by 30%. Another finding was how
the effect of interventions differed across specialties. Both
interventions were more effective at the pulmonary wards,
than wards of infectious diseases and gastroenterology.
Interventions to improve antibiotic prescribing practices
have shown a 15% average increase in adherent prescrib-
ing in intervention wards, however the effect depends on
how they are designed and implemented [6, 18]. When
Schouten et al. tailored interventions to each intervention
hospital; they achieved an average 14% increase in adher-
ence to guidelines for empiric treatment of lower respira-
tory tract infections (LRTI). The level of change was very
similar for all the intervention hospitals, although it was
not stated how the patients were distributed across the
wards of internal- and pulmonary medicine [19]. Their re-
sults are comparable to our findings at the pulmonary
wards, with a 14% absolute change in adherence to guide-
lines, while it differs substantially from effects seen across
infectious diseases and gastroenterology wards. A single
site Norwegian study focusing on pneumonia and COPD
exacerbations within pulmonary medicine, added a pocket
guideline to their audit with feedback intervention [20].
From a baseline adherence of 62%, similar to our study,
adherence was increased by 22%.
Involving clinicians in identifying challenges, finding
solutions and setting local targets is both reasonable and
recommended and has previously proven effective in in-
creasing compliance to target behaviour [6, 21–23].
Jobson et al. increased the timeliness of antibiotics for fe-
brile patients with central lines presenting in the ED from
63 to 99% [23]. They exceeded their goal of 90% timeliness
through active engagement of the caregiving staff and the
use of multiple plan-study-do-act-cycles (PDSA-cycles)
[24]. At the pulmonary ward at hospital A, the audit data
made it easy for clinicians to identify local challenges and
set a specific, measureable, attractive and realistic target
for change in prescribing behaviour and we found a simi-
lar change of 30% increase in target behaviour.
The wards receiving audit with feedback had different
case-mix. In infectious diseases, 41% of patients were treated
for pneumonia and COPD exacerbations, compared to 71%
in the pulmonary ward. This could partly explain the lack of
effect seen in the infectious disease ward, as pneumonia and
COPD exacerbations were the selected focus for the feed-
back sessions. Empirical therapy according to guidelines
across diagnoses was the main outcome measure for all
intervention wards. Pre-audits at every intervention ward
would have made it easier to identify each ward’s prescribing
challenges, and tailor the interventions to context specific
improvement areas for each ward. As this study is
Table 4 Local targets set by study intervention wards and outcome for targeted change in prescribing practice





Increase the use of Penicillin G 2 mill IU × 4 to treat
pneumonia (CAP) and infectious COPD exacerbations





Reduce ciprofloxacin use for inflammatory bowel
disease, and shift to Co-trimoxazol
(indication outside national antibiotic guideline)
Too few patients with targeted indication to
assess outcome by indication.
Assessed by use of sales statistics. Reduction
in use of Ciprofloxacin at 3, 6, 12 and 18 months







- Reevaluation of initiated treatment on arrival to ward
and - after 48–72 h
- Increase use of CRB-65 and antibiotic guideline






- Increase use of Penicillin G 2 mill × 4 to treat infectious
COPD exacerbations
- Reassess length of iv-antibiotics for patients with
osteomyelitis
- Increase consultants presence in the emergency room
to increase guidelines adherence on admission
- Reevaluation of treatment during the patient stay





No target area identified. No target area identified
aBy chi-square test bBy Interrupted time series analysis (Appendix Table 6)
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intervening in the very heart of ID-specialists’ area of expert-
ise, it may also be a bigger challenge to advocate a shift in
prescribing practice towards general antibiotic guidelines,
limiting the autonomy of the prescriber [25].
The national guideline was published approximately
6 months prior to study initiation and some wards had
already started promoting its use [16]. A previous study
by Skodvin et al. showed that interns and residents heav-
ily relied on guidelines when initiating antibiotic treat-
ment [26]. This could have caused a positive shift in
prescribing practice already, decreasing the potential for
absolute effect of interventions. Including physicians
mainly working in the emergency room in interventions
could have given increased effects, but intervention and
control wards at the same hospital would then be chal-
lenging because of spill over effects between the wards.
Champions can play a powerful role in behaviour
change [25, 26]. Special emphasis was made on using local
champions for developing and implementing interven-
tions as they are familiar to the ward physicians, know
possible barriers and facilitators and could tailor the pre-
sentations to the ward’s needs. Local involvement could
also increase the chance of continuous work within the
area after study completion. An example of tailoring is
adding information about a previous local outbreak of
Vancomycin-resistant enterococci (VRE) to the audit with
feedback session at the pulmonary ward at Hospital A, to
increase local ownership. At the gastroenterology ward,
academic detailing was performed by an ID-physician.
During evaluation, he suggested that including a physician
from the gastroenterology ward could have increased the
ownership of the intervention and the identified target. In-
terventions were only applied at one time-point during
the study period. Adding more intervention sessions could
probably have increased the effects seen [6].
We aimed to achieve responsible antibiotic prescribing
practice in a complex hospital setting. This study is a “real-
life” study, including the most common infections treated
at hospitals in the western world and three specialties in
three separate hospitals where patterns of prescribing may
differ, as will patient mix. All three hospitals and specialties
contributed both to the intervention and control groups,
reducing the potential for confounding and increasing ex-
ternal validity of the findings. The study was initiated in a
“normal” clinical situation and not as a response to an out-
break. Random time effects should therefore be reduced.
Seasonality is likely, but the inclusion of control groups
within the same time period allow us to control for the ef-
fects. Findings should be generalizable to other hospital
wards within the same specialties and in settings with a
similar, relatively flat organizational structure.
The short post-intervention period and skewness of data
between pre- and post-intervention periods is the major limi-
tation to this study, caused by the fixed date for study period
when applying for study approval and the substantial work-
load for manual data collection of individual prescription
data. This also led to insufficient power to look at interven-
tion effect on adherence at each cluster. Activity-adjusted
antibiotic sales statistics for broad-spectrum antibiotics pro-
vides however the opportunity to assess change in levels and
trends of broad-spectrum antibiotic use, indicating prescrib-
ing behaviour over longer periods of time.
In our study we found that the context we implemented
interventions in were even more important than the type
of intervention selected. Tailoring the interventions to the
local context and challenges of each study ward and more
focus on using SMART1 goals during the planning and
implementation of interventions, could increase the possi-
bility to get the desired outcomes. LRTIs are common in
stewardship intervention studies [6, 18]. It is a wise place
to start optimization of antibiotic prescribing, because the
volume of patients secures great impact on total antibiotic
use. More severe diagnoses, like infections in immuno-
compromised patients may be a bigger challenge to target
in behaviour change. Especially inexperienced physicians
may feel the need to secure adequate coverage with
broad-spectrum antibiotics at treatment initiation and the
thought of “never change a winning team” may lead to
lack of re-evaluation and focusing treatment [26].
When designing behavioural change interventions in
antibiotic stewardship programs, we need careful plan-
ning. Attention should be paid to local barriers and facili-
tators for change and we should have in-depth knowledge
of local antibiotic prescribing practices and case mix to
guide the focus of interventions.
Conclusions
Pulmonary intervention wards had an increase in adher-
ence, independent of applied intervention, while no effect
was seen at wards of infectious diseases and gastroenter-
ology. This shows that the context in which interventions
are implemented is important and may also indicate that
pulmonary wards may be a good place to start when chan-
ging antibiotic prescribing behavior in similar hospital set-
tings. We also showed that when ward physicians were
actively involved in the process of discussing their own
prescribing behavior and could identify and agree on spe-
cific targets for change in prescribing practice, great
change was achieved within a short timeframe.
Endnotes
1SMART: Specific, Measurable, Attractive, Realistic
and Time-bound
Appendix
Appendix show results for interrupted time series analysis
of the use of broad- spectrum antibiotics for intervention
groups and specialties:
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Table 6 Interrupted Time Series analysis of the use of Ciprofloxacin at the ward of Gastroenterology, Hospital A, from 2013 to 2015
Estimate SE p-value
Ciprofloxacin DDD per 100 bed days Constant 10.291 1.283 0.000
AR −0.090 0.520 0.868
Pre-slope −0.169 0.341 0.636
Difference between pre- and post-slope −0.106 0.461 0.825
Level effect
3 months −4.254 1.905 0.061
6 months −4.360 1.956 0.061
12 months −4.571 2.343 0.092
18 months −4.783 2.975 0.152
Use of Ciprofloxacin is measured as quarterly sales of Ciprofloxacin, adjusted for bed days
Fig. 1 Use of broad-spectrum antibiotics at intervention wards and per specialty intervention wards compared to control wards
Wathne et al. Antimicrobial Resistance and Infection Control  (2018) 7:109 Page 10 of 12
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